Nanopore sequencing quickly and accurately diagnoses rare genetic disorders
This third-generation sequencing tool may simplify genetic sample processing and decrease analysis time resulting in improved patient care
This third-generation sequencing tool may simplify genetic sample processing and decrease analysis time resulting in improved patient care
The startup will develop and commercialize cost-effective, highly sensitive, and specific point-of-care diagnostics, applying a novel electrochemical sensor platform created at the Wyss Institute
MINI 96 electronic pipette wins SelectScience General Lab Scientists’ Choice Award
EKF Diagnostics exhibiting range of tests and analyzers on Booth #3637
Highly sensitive droplet digital PCR-based liquid biopsies can detect the smallest amounts of residual cancer DNA and help oncologists refine treatment decisions for a variety of cancers
Errors, hands-on time reduced through powerful automation features
The analysis hopes to unlock the secrets behind the formation of our solar system
The world’s top minds in the field of cell and immunotherapy gathered in Philadelphia, PA to share cutting-edge science and technology in the single cell analysis domain.
Potential treatments identified that may offer improved outcomes in COVID-19 patients with increased thrombus formation
The cutting-edge software module is intended to address the expanding scientific demand for complicated 3D in-vitro models from academics and drug developers
The Rigaku ResQ CQL 1064 nm handheld Raman analyzer will be deployed globally as part of the U.S. Dismounted Reconnaissance Sets, Kits, and Outfits (DR SKO) Program
The company announces new mass spectrometry instruments, workflows, software and industry collaborations during ASMS 2022 Conference
International competition rewards top proteomics researchers for outstanding innovation and societal impact
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform
The Jackson Laboratory describes how humanized mice provide a new generation of tools for the preclinical development of drugs recognizing human-specific targets